Geographic · Property, plant, and equipment, net
Outside United States — Property, plant, and equipment, net
Regeneron Pharmaceuticals Outside United States — Property, plant, and equipment, net increased by 10.1% to $788.00M in Q4 2025 compared to the prior quarter.
Analysis
StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2023
Last reportedQ4 2025
Rolls up toProperty, plant and equipment, net
How to read this metric
An increase suggests expansion of international manufacturing or research capacity, while a decrease may indicate asset divestiture, impairment, or a shift toward third-party contract manufacturing models.
Detailed definition
This metric represents the net book value of tangible long-term assets, such as manufacturing facilities, laboratories,...
Peer comparison
Peers in the pharmaceutical industry typically report similar geographic splits of fixed assets to demonstrate their global manufacturing strategy and reliance on international production hubs.
Metric ID:
regn_segment_non_us_property_plant_and_equipment_netHistorical Data
3 periods
| Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|
| Value | $771.40M | $715.90M | $788.00M |
| QoQ Change | — | -7.2% | +10.1% |
| YoY Change | — | -7.2% | +10.1% |
Range$715.90M – $788.00M
Avg YoY Growth+1.4%
Median YoY Growth+1.4%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Regeneron Pharmaceuticals's outside united states — property, plant, and equipment, net?
- Regeneron Pharmaceuticals (REGN) reported outside united states — property, plant, and equipment, net of $788.00M in Q4 2025.
- What does outside united states — property, plant, and equipment, net mean?
- The total value of the company's physical assets, such as buildings and equipment, located outside of its home country after accounting for depreciation.